Investigations of Hydrazine Cleavage of Eltrombopag in HumansYANLI DENG; ROGERS, Martin; GORYCKI, Peter D et al.Drug metabolism and disposition. 2011, Vol 39, Num 9, pp 1747-1754, issn 0090-9556, 8 p.Article

Eltrombopag : An effective remedy for thrombocytopaenia?MONDELLI, Mario U.Journal of hepatology. 2008, Vol 48, Num 6, pp 1030-1032, issn 0168-8278, 3 p.Article

TGFβ1 and sCTLA-4 levels are increased in eltrombopag-exposed patients with ITPFUJITA, Shinya; NAKANISHI, Takahisa; YOSHIMURA, Hideaki et al.Thrombosis research. 2012, Vol 130, Num 3, pp 415-419, issn 0049-3848, 5 p.Article

Eltrombopag for the Treatment of Chronic Idiopathic Thrombocytopenic PurpuraBUSSEL, James B; CHENG, Gregory; ARNING, Michael et al.The New England journal of medicine. 2007, Vol 357, Num 22, pp 2237-2247, issn 0028-4793, 11 p.Article

The biology of thrombopoietin and thrombopoietin receptor agonists : PIH: Pathophysiology and management of trombocytopenia: Possible clinical application of TPO receptor agonistsKUTER, David J.International journal of hematology. 2013, Vol 98, Num 1, pp 10-23, issn 0925-5710, 14 p.Article

Pharmacokinetics and Hepatic Uptake of Eltrombopag, a Novel Platelet-Increasing AgentTAKEUCHI, Kazuya; SUGIURA, Tomoko; UMEDA, Saki et al.Drug metabolism and disposition. 2011, Vol 39, Num 6, pp 1088-1096, issn 0090-9556, 9 p.Article

The pharmacology and clinical application of thrombopoietin receptor agonistsCAIZHENG LI; LI ZHENG.International journal of hematology. 2014, Vol 100, Num 6, pp 529-539, issn 0925-5710, 11 p.Article

Use of eltrombopag, a thrombopoietin receptor agonist, in post-transplantation thrombocytopeniaREID, Robin; BENNETT, John M; BECKER, Michael et al.American journal of hematology. 2012, Vol 87, Num 7, pp 743-745, issn 0361-8609, 3 p.Article

Eltrombopag: An Oral Thrombopoietin Receptor Agonist for the Treatment of Idiopathic Thrombocytopenic PurpuraYANG ZHANG; KOLESAR, Jill M.Clinical therapeutics. 2011, Vol 33, Num 11, pp 1560-1576, issn 0149-2918, 17 p.Article

Agonistes du récepteur de la thrombopoïétine et prise en charge des thrombopénies. Actualités et perspectives : Facteurs de CroissanceGODEAU, Bertrand; KHELLAF, Mehdi; MICHEL, Marc et al.MT. Médecine thérapeutique. 2009, Vol 15, Num 4, pp 279-286, issn 1264-6520, 8 p.Article

In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activationPSAILA, Bethan; BUSSEL, James B; LINDEN, Matthew D et al.Blood. 2012, Vol 119, Num 17, pp 4066-4072, issn 0006-4971, 7 p.Article

Eltrombopag, an oral thrombopoietin receptor agonist, has no impact on the pharmacokinetic profile of probe drugs for cytochrome P450 isoenzymes CYP3A4, CYP1A2, CYP2C9 and CYP2C19 in healthy men: a cocktail analysisJENKINS, Julian; WILLIAMS, Daphne; YANLI DENG et al.European journal of clinical pharmacology. 2010, Vol 66, Num 1, pp 67-76, issn 0031-6970, 10 p.Article

Eltrombopag does not affect cardiac repolarization: results from a definitive QT_c study in healthy subjectsMATTHYS, Gemma; JUNG WOOK PARK; MCGUIRE, Sandra et al.British journal of clinical pharmacology. 2010, Vol 70, Num 1, pp 24-33, issn 0306-5251, 10 p.Article

Thrombopoietin receptor agonists in the treatment of thrombocytopeniaNEWLAND, Adrian.Current opinion in hematology. 2009, Vol 16, Num 5, pp 357-364, issn 1065-6251, 8 p.Article

De nouvelles perspectives dans le traitement du purpura thrombopénique idiopathique : les agonistes des récepteurs à la thrombopoïétineWAGNER, Sophie; CIOBANU, Ecaterina; FEDERICI, Laure et al.MT. Médecine thérapeutique. 2008, Vol 14, Num 2, pp 96-104, issn 1264-6520, 9 p.Article

Metabolism and Disposition of Eltrombopag, an Oral, Nonpeptide Thrombopoietin Receptor Agonist, in Healthy Human SubjectsYANLI DENG; MADATIAN, Armina; GORYCKI, Peter D et al.Drug metabolism and disposition. 2011, Vol 39, Num 9, pp 1734-1746, issn 0090-9556, 13 p.Article

Severe cutaneous toxicity related to EltrombopagMEYER, Sara C; ROVO, Alicia; TSAKIRIS, Dimitrios A et al.British journal of haematology. 2013, Vol 160, Num 3, pp 412-414, issn 0007-1048, 3 p.Article

Prolonged remission from eltrombopag in chronic refractory idiopathic thrombocytopenic purpuraNORONHA, V; PHILIP, S. D; JOSHI, A et al.International journal of hematology. 2012, Vol 96, Num 3, pp 380-382, issn 0925-5710, 3 p.Article

Thrombopoietin receptor agonists in refractory immune thrombocytopenia: differential responses to eltrombopag and romiplostim: a case report and possible explanationsAOKI, T; HARADA, Y; MATSUBARA, E et al.Journal of clinical pharmacy and therapeutics (Print). 2012, Vol 37, Num 6, pp 729-732, issn 0269-4727, 4 p.Article

Eltrombopag (₇₅ mg) does not induce photosensitivity: results of a clinical pharmacology trialBOWEN, Carolyn J; LOBB, Kathryn M; JUNG WOOK PARK et al.Photodermatology photoimmunology & photomedicine. 2010, Vol 26, Num 5, pp 243-249, issn 0905-4383, 7 p.Article

Effects of Food and Antacids on the Pharmacokinetics of Eltrombopag in Healthy Adult Subjects: Two Single-Dose, Open-Label, Randomized-Sequence, Crossover StudiesWILLIAMS, Daphne D; BIN PENG; BAILEY, Christine K et al.Clinical therapeutics. 2009, Vol 31, Num 4, pp 764-776, issn 0149-2918, 13 p.Article

Successful treatment of aplastic anaemia associated with HIV infection with eltrombopag: implications for a possible immunomodulatory roleBART-SMITH, Emily E; KORDASTI, Shahram; KULASEKARARAJ, Austin G et al.AIDS (London). 2014, Vol 28, Num 18, pp 2786-2788, issn 0269-9370, 3 p.Article

Eltrombopag for the treatment of the inherited thrombocytopenia deriving from MYH9 mutationsPECCI, Alessandro; GRESELE, Paolo; KLERSY, Catherine et al.Blood. 2010, Vol 116, Num 26, pp 5832-5837, issn 0006-4971, 6 p.Article

Successful treatment of eltrombopag-resistant refractory immune thrombocytopenia with romiplostimNAKAZATO, Tomonori; ITO, Chisako; MIHARA, Ai et al.International journal of hematology. 2013, Vol 97, Num 2, pp 291-293, issn 0925-5710, 3 p.Article

Eltrombopag therapy in newly diagnosed steroid non-responsive ITP patientsANIL KUMAR TRIPATHI; SHUKLA, Ayush; MISHRA, Sanjay et al.International journal of hematology. 2014, Vol 99, Num 4, pp 413-417, issn 0925-5710, 5 p.Article